Who owns INTEGRA LIFESCIENCES HLDGS C?
- CUSIP Number: 457985am1
Tip: Access positions for across all investors
Analyze quarterly positions in Integra Lifesciences Hldgs C with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Integra Lifesciences Hldgs C stock
Who bought or sold INTEGRA LIFESCIENCES HLDGS C this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 103M | $99M | 100% | Mar 2024 |
|
| Tenor Capital Management | 59M | $57B | 142% | Mar 2024 |
|
| Highbridge Capital Management | 51M | $48B | -6% | Mar 2024 |
|
| Nuveen Asset Management | 30M | $29M | 100% | Mar 2024 |
|
| Millennium Management | 27M | $26M | 100% | Mar 2024 |
|
| MacKay Shields | 25M | $24M | -1% | Mar 2024 |
|
| Balyasny Asset Management | 25M | $24M | 0% | Mar 2024 |
|
| Citigroup | 17M | $17M | -33% | Mar 2024 |
|
| Aviva | 17M | $16M | -30% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 16M | $15M | 1013% | Mar 2024 |
|
| Wellington Management Company | 12M | $11M | 22% | Dec 2023 |
|
| DLD Asset Management | 9.0M | $8.5M | -46% | Dec 2023 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 8.0M | $7.7M | 0% | Mar 2024 |
|
| Ofi Invest Asset Management | 6.6M | $12M | 91658% | Mar 2024 |
|
| Bnp Paribas Investment Partners | 4.5M | $4.3M | 0% | Mar 2024 |
|
| BlackRock | 4.4M | $4.2M | 10% | Mar 2024 |
|
| Morgan Stanley | 4.2M | $4.0M | 22% | Mar 2024 |
|
| Palisade Capital Management | 3.9M | $3.8M | -3% | Mar 2024 |
|
| Man Group | 3.2M | $3.0M | -23% | Mar 2024 |
|
| Jpmorgan Chase & Co | 3.1M | $2.9M | -62% | Mar 2024 |
|
| Calamos Advisors | 2.8M | $2.6M | -23% | Mar 2024 |
|
| Royal Bank of Canada | 2.7M | $2.6M | -42% | Mar 2024 |
|
| Leucadia National Corporation | 2.6M | $2.5M | -61% | Mar 2024 |
|
| Wells Fargo & Company | 1.9M | $1.8M | -89% | Mar 2024 |
|
| Liberty Mutual Group Asset Management | 1.5M | $1.4M | -47% | Mar 2024 |
|
| Lazard Asset Management | 1.4M | $1.3M | 0% | Dec 2023 |
|
| Bank Of Montreal | 1.1M | $1.1M | -88% | Mar 2024 |
|
| American Century Companies | 317k | $303k | 27% | Mar 2024 |
|
| Barclays | 287k | $275k | 22% | Mar 2024 |
|
| Sei Investments | 249k | $237k | 0% | Mar 2024 |
|
| Oppenheimer Asset Management | 106k | $101k | -45% | Mar 2024 |
|
| Stephens | 101k | $96k | 135% | Mar 2024 |
|
| KBC Group NV | 100k | $96k | -67% | Mar 2024 |
|
| Bank of America Corporation | 55k | $52k | -99% | Mar 2024 |
|
| Us Bancorp | 52k | $50k | 0% | Mar 2024 |
|
| Argent Trust | 35k | $33k | 0% | Mar 2024 |
|
| Balboa Wealth Partners | 33k | $32k | 0% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 12k | $11k | -20% | Mar 2024 |
|
| Nomura Holdings | 11k | $403k | -82% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 5.0k | $4.8k | 0% | Mar 2024 |
|
| Brian McDonald | 2.0k | $1.9k | -33% | Mar 2024 |
|
Who sold out of Integra Lifesciences Hldgs C?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Shaolin Capital Management | Sep 2023 | 53M | $48M |
| Linden Advisors | Sep 2023 | 37M | $33B |
| III Capital Management | Dec 2023 | 35M | $33M |
| Capstone Investment Advisors | Dec 2023 | 19M | $18M |
| Aequim Alternative Investments | Dec 2023 | 18M | $17M |
| Osterweis Capital Management | Dec 2023 | 13M | $12M |
| Shenkman Capital Management | Dec 2023 | 11M | $10B |
| Boothbay Fund Management | Sep 2023 | 6.2M | $5.6M |
| Opti Capital Management | Sep 2023 | 4.5M | $4.1M |
| Flow State Investments | Sep 2023 | 4.0M | $3.7M |
| Credit Suisse | Dec 2023 | 2.8M | $2.8M |
| Lombard Odier Asset Management | Sep 2023 | 2.2M | $2.0M |
| Worth Venture Partners | Dec 2023 | 1.6M | $1.5M |
| SSI Investment Management | Sep 2023 | 525k | $479k |
| Zurcher Kantonalbank | Dec 2023 | 400k | $377k |
| Calamos Wealth Management | Dec 2023 | 146k | $138k |
| SG Americas Securities | Dec 2023 | 15k | $1.4M |